Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Conclusion of a non-exclusive discount agreement pursuant to Section 130A Paragraph 8 of the Social Code Book V for medicinal products containing the active ingredient Natalizumab (ATC code: L04Ag03).
Deadline - Jul 27, 2027
GT reference number - 114927043
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 114927043
Document Type - Tender Notices
Description - notice_title: Conclusion of a non-exclusive discount agreement pursuant to Section 130A Paragraph 8 of the Social Code Book V for medicinal products containing the active ingredient Natalizumab (ATC code: L04Ag03).local title:: Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Natalizumab (ATC-Code: L04AG03).Contract Type: : Supplylocal description: : Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Natalizumab (ATC-Code: L04AG03) innerhalb des Zeitraumes vom 01.10.2025 bis zum 30.09.2027 mit jederzeitiger Möglichkeit des Vertragsabschlusses während der Laufzeit („open
Gt Ref Id - 114927043
Deadline - Jul 27, 2027
Similar Tenders :
Summary:
|
Summary:
|
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database